Development of the Therapeutics for Autoimmune Disorders Showing Clinical and Pathological Variance |
| T. Yamamura and K. Chiba |
| J. Pharm. Soc. Jpn., 129(6),647-648, 2009 |
|
Immunoregulation by iNKT Cells |
| S. Miyake |
| J. Pharm. Soc. Jpn., 129(6),649-653, 2009 |
|
A New Therapeutic Approach for Autoimmune Diseases by the Sphingosine 1-Phosphate Receptor Modulator, Fingolimod (FTY720) |
| K. Chiba |
| J. Pharm. Soc. Jpn., 129(6),655-665, 2009 |
|
A New Therapeutic Strategy for Autoimmune and Chronic Inflammatory Disease Based on Clinical Results Using IL-6 Blocking Therapy with a Humanized Anti-IL-6 Receptor Antibody |
| K. Yoshizaki |
| J. Pharm. Soc. Jpn., 129(6),667-674, 2009 |
|
B Cell Targeting Therapy Using the Anti-CD20 Antibody in Autoimmune Diseases |
| Y. Tanaka |
| J. Pharm. Soc. Jpn., 129(6),675-679, 2009 |
|
Carbohydrate Study for 40 Years |
| T. Takeda |
| J. Pharm. Soc. Jpn., 129(6),681-698, 2009 |
|
Clinical, Epidemiological and Pharmacological Research on Cardiovascular Disease Based on Blood Pressure Variability |
| T. Ohkubo |
| J. Pharm. Soc. Jpn., 129(6),699-708, 2009 |
|
Design and Synthesis of Peroxisome Proliferator-activated Receptor (PPAR) Delta Agonists and Its Implication to the Driving Force to Elicit PPAR Delta Selectivity |
| J. Kasuga, T. Oyama, I. Nakagome, A. Aoyama, K. Sako, M. Makishima, S. Hirono, K. Morikawa, Y. Hashimoto, and H. Miyachi |
| J. Pharm. Soc. Jpn., 129(6),709-718, 2009 |
|
Simple and Rapid Screening for Psychotropic Natural Products Using Direct Analysis in Real Time (DART)-TOFMS |
| M. Kawamura, R. Kikura-Hanajiri, and Y. Goda |
| J. Pharm. Soc. Jpn., 129(6),719-725, 2009 |
|
Analysis of Background Factors Influencing In-home Patient Adherence: Comparison between True Adherence and Predicted Adherence by Home-helpers |
| N. Hatanaka, T. Itoh, M. Ishihata, M. Kojima, E. Nemoto, S. Ohshima, and D. Kobayashi |
| J. Pharm. Soc. Jpn., 129(6),727-734, 2009 |
|
The Role of Pharmacists in a Community Pharmacy for Self-Medication of Patients with Headache |
| Y. Naito, M. Ishii, K. Kawana, Y. Sakairi, S. Shimizu, and Y. Kiuchi |
| J. Pharm. Soc. Jpn., 129(6),735-740, 2009 |
|
The Need for Collaboration between Community Pharmacies and Hospitals or Clinics in Providing Medical Treatment for Patients with Headache |
| Y. Naito, M. Ishii, Y. Sakairi, K. Kawana, S. Shimizu, and Y. Kiuchi |
| J. Pharm. Soc. Jpn., 129(6),741-748, 2009 |
|
Clinical Trial Simulations for Dosage Optimization of Docetaxel in Patients with Liver Dysfunction, Based on a Log-binominal Regression for Febrile Neutropenia |
| K. Ozawa, H. Minami, and H. Sato |
| J. Pharm. Soc. Jpn., 129(6),749-757, 2009 |
|
Pharmaceutical Analysis and Clinical Efficacy of Kampo Medicine, Maoto, Extract Suppository Against Pediatric Febrile Symptoms |
| N. Nishimura, N. Doi, T. Uemura, T. Taketani, G. Hayashi, T. Kasai, R. Kanai, S. Yamaguchi, K. Iwamoto, and K. Naora |
| J. Pharm. Soc. Jpn., 129(6),759-766, 2009 |
|
Development of New Mixing Method of Busulfex® Injecton for the Purpose of Improvement of Medical Safety Method; The Prefilled Syringe Method |
| M. Senoo, K. Tajika, H. Shimizu, M. Hamada, Y. Dobashi, A. Dobashi, K. Dan, and S. Katayama |
| J. Pharm. Soc. Jpn., 129(6),767-771, 2009 |
|
Development and Evaluation of an Internet-based Educational System about Herbs and Dietary Supplements through Periodical Distribution of Information to Health Professionals |
| Y. Asahina, S. Hori, H. Ohtani, and Y. Sawada |
| J. Pharm. Soc. Jpn., 129(6),773-780, 2009 |
|